Atul Gawande

Alto Neuroscience Appoints Andrew Dreyfus to Its Board of Directors

Retrieved on: 
Wednesday, October 18, 2023

Alto Neuroscience today announced the appointment of Andrew Dreyfus, former president and CEO of BCBSMA, to the company’s board of directors as an independent board member.

Key Points: 
  • Alto Neuroscience today announced the appointment of Andrew Dreyfus, former president and CEO of BCBSMA, to the company’s board of directors as an independent board member.
  • Mr. Dreyfus brings decades of experience in health insurance and healthcare reform to support the advancement of Alto’s late-stage precision psychiatry pipeline.
  • “His unique experience at the intersection of insurance and policy will be invaluable as we continue to build our clinical development strategy.
  • “I am honored to join the Alto board of directors at such a pivotal stage in the company’s development, coinciding with a time of continued unmet need in our country’s mental healthcare,” added Andrew Dreyfus.

Rita And Alex Hillman Foundation Awards Innovation Dissemination Grant to TeamBirth

Retrieved on: 
Tuesday, September 26, 2023

NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Affirming its commitment to scaling evidence-based, nursing-driven interventions that provide equitable, person-centered, and trustworthy care, The Rita and Alex Hillman Foundation today announced a $200,000 Hillman Innovation Dissemination (HID) grant to TeamBirth .

Key Points: 
  • NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Affirming its commitment to scaling evidence-based, nursing-driven interventions that provide equitable, person-centered, and trustworthy care, The Rita and Alex Hillman Foundation today announced a $200,000 Hillman Innovation Dissemination (HID) grant to TeamBirth .
  • “At a time when one in five pregnant people experience mistreatment during childbirth, and up to 40 percent of Black and multiracial patients report discrimination while receiving maternity care, it is imperative that interventions like TeamBirth are made widely available,” said Ahrin Mishan, Executive Director of The Rita and Alex Hillman Foundation.
  • “We are proud to support the expansion of this important intervention.”
    Developed by Ariadne Labs – a joint center for health systems innovation at Brigham and Women’s Hospital and Harvard’s T.H.
  • “Funding from The Rita and Alex Hillman Foundation comes at a critical time,” said Amber Weiseth, DNP, MSN, RN, Director of the Ariadne Labs’ Delivery Decisions Initiative and the principal investigator of the HID grant.

Wolters Kluwer discusses Best Care Everywhere commitment to health equity on MarketScale

Retrieved on: 
Tuesday, June 27, 2023

Stacey Caywood, Chief Executive Officer of Wolters Kluwer Health , is focused on identifying ways to overcome the long-term challenges of widespread inequities in global health.

Key Points: 
  • Stacey Caywood, Chief Executive Officer of Wolters Kluwer Health , is focused on identifying ways to overcome the long-term challenges of widespread inequities in global health.
  • In her discussion with MarketScale, Caywood emphasizes that tackling health inequity “is in our DNA” at Wolters Kluwer, to deliver the best care everywhere.
  • She discusses the three steps Wolters Kluwer is taking to address the ongoing challenge of achieving health equity.
  • The division of Wolters Kluwer supports clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

Ariadne Labs and Genomes2People Launch New Precision Population Health Initiative

Retrieved on: 
Tuesday, March 23, 2021

BOSTON, March 23, 2021 /PRNewswire/ --Ariadne Labs today announced the launch of the Precision Population Health initiative.

Key Points: 
  • BOSTON, March 23, 2021 /PRNewswire/ --Ariadne Labs today announced the launch of the Precision Population Health initiative.
  • Ariadne Labs has been exploring the role of precision medicine in primary health care since 2018 as part of the organization's Spark Grant innovation incubation pipeline .
  • "If precision medicine is to be fully integrated into population health and the day-to-day practice of medicine at scale, significant health system innovations will be required," said Atul Gawande, MD, MPH, Founder and Chair of Ariadne Labs.
  • "We are excited to be collaborating on this important Precision Population Health initiative.

Ariadne Labs Founder Dr. Atul Gawande Named to Biden-Harris Transition COVID-19 Advisory Board

Retrieved on: 
Monday, November 9, 2020

BOSTON, Nov. 9, 2020 /PRNewswire/ --Dr. Atul Gawandefounder and chair of Ariadne Labs , Brigham and Women's Hospital surgeon, Harvard professor, and best-selling authorwas named today as a member of President-elect Biden's Transition COVID-19 Advisory Board.

Key Points: 
  • BOSTON, Nov. 9, 2020 /PRNewswire/ --Dr. Atul Gawandefounder and chair of Ariadne Labs , Brigham and Women's Hospital surgeon, Harvard professor, and best-selling authorwas named today as a member of President-elect Biden's Transition COVID-19 Advisory Board.
  • The COVID-19 Advisory Board is a team of leading public health experts who will advise President-elect Biden, Vice President-elect Harris, and the Transition's COVID-19 staff.
  • Ariadne Labs is a joint center for health systems innovation at Brigham and Women's Hospital and Harvard T.H.
  • Visit ariadnelabs.org to learn more and covid19.ariadnelabs.org to learn about Ariadne Labs' response to COVID-19.

Physician-writer Siddhartha Mukherjee will be awarded the 2019 Lewis Thomas Prize

Retrieved on: 
Monday, April 15, 2019

NEW YORK, April 15, 2019 /PRNewswire/ --Siddhartha Mukherjee has delighted, informed, and touched a wide audience through his books and essays, for which he will be awarded the 2019 Lewis Thomas Prize for Writing about Science .

Key Points: 
  • NEW YORK, April 15, 2019 /PRNewswire/ --Siddhartha Mukherjee has delighted, informed, and touched a wide audience through his books and essays, for which he will be awarded the 2019 Lewis Thomas Prize for Writing about Science .
  • The prize, honoring scientists as inspirational authors, will be presented Monday, April 22, at a free, public event on The Rockefeller University campus.
  • "Mukherjee's willingness and ability to bring cancer to a human level epitomizes the 'scientist as poet' spirit of the Lewis Thomas Prize," says Jesse H. Ausubel, chair of the selection committee.
  • Recent recipients of the Lewis Thomas Prize include astrophysicist Kip Thorne, oceanographer Sylvia Earle, physiologist Frances Ashcroft, surgeon Atul Gawande, and mathematicians Steven Strogatz and Ian Stewart.

Amazon, Berkshire Hathaway, JPMorgan Chase Health Care Venture Launches Website and Announces Its Name: Haven

Retrieved on: 
Wednesday, March 6, 2019

Today, the health care organization founded by Amazon (NASDAQ: AMZN), Berkshire Hathaway (NYSE: BRK.A, BRK.B), and JPMorgan Chase (NYSE: JPM), announced its name Haven and launched a new website at www.havenhealthcare.com .

Key Points: 
  • Today, the health care organization founded by Amazon (NASDAQ: AMZN), Berkshire Hathaway (NYSE: BRK.A, BRK.B), and JPMorgan Chase (NYSE: JPM), announced its name Haven and launched a new website at www.havenhealthcare.com .
  • View the full release here: https://www.businesswire.com/news/home/20190306005660/en/
    Amazon, Berkshire Hathaway, JPMorgan Chase Health Care Venture Launches Website and Announces Its Name: Haven (Graphic: Business Wire)
    We want to change the way people experience health care so that it is simpler, better, and lower cost, explained Haven CEO Atul Gawande, MD, MPH.
  • In recent months, Dr. Gawande has been meeting with Amazon, Berkshire Hathaway, and JPMorgan Chase employees to understand their health care experiences.
  • Haven is an independent health care organization founded by Amazon (NASDAQ: AMZN), Berkshire Hathaway (NYSE: BRK.A, BRK.B) and JPMorgan Chase (NYSE: JPM).